Glenmark Pharmaceuticals Technical Analysis

Glenmark Pharmaceuticals Ltd Technical Analysis

Glenmark Pharmaceuticals Ltd technical analysis is gaining attention among traders and investors tracking Glenmark Pharmaceuticals Ltd Technical Analysis trends in the Indian stock market. Glenmark Pharmaceuticals Ltd (NSE: GLENMARK, BSE: 532296) is currently trading at ₹2136.70, showing a 0.58% move as of Tue, Mar 10, 2026.

This detailed Glenmark Pharmaceuticals Ltd technical analysis covers support & resistance levels, moving averages, indicators, and overall market sentiment to help investors make informed decisions.

Glenmark Pharmaceuticals Ltd Stock Overview

Glenmark Pharmaceuticals Ltd operates in the Health technology sector under the Pharmaceuticals: major industry. With a market capitalization of ₹603.26B and a PE ratio of 56.64, Glenmark Pharmaceuticals Ltd remains a key stock to watch in Glenmark Pharmaceuticals Ltd Technical Analysis searches.

Key Metrics

• Market Cap: ₹603.26B
• PE Ratio: 56.64
• Dividend Yield: 0.23
• Sector: Health technology
• Industry: Pharmaceuticals: major

These fundamentals play an important role in Glenmark Pharmaceuticals Ltd technical analysis and valuation tracking.

Glenmark Pharmaceuticals Ltd Support and Resistance Levels

Classic Pivot Levels

In Glenmark Pharmaceuticals Ltd technical analysis, pivot levels help identify potential reversal and breakout zones.

• Resistance 3: 2681.77
• Resistance 2: 2363.97
• Resistance 1: 2250.33
• Pivot Point: 2046.17
• Support 1: 1932.53
• Support 2: 1728.37
• Support 3: 1410.57

Conditional Insight

Glenmark Pharmaceuticals Ltd technical analysis suggests a bearish to neutral trend as the price is below the pivot point. Immediate support is seen near 1932.53 and 1728.37.

Fibonacci Levels Analysis

Fibonacci levels are widely used in Glenmark Pharmaceuticals Ltd technical analysis to identify retracement zones.

• Fibonacci R3: 2363.97
• Fibonacci R2: 2242.57
• Fibonacci R1: 2167.57
• Fibonacci Pivot: 2046.17
• Fibonacci S1: 1924.77
• Fibonacci S2: 1849.77
• Fibonacci S3: 1728.37

Glenmark Pharmaceuticals Ltd technical analysis indicates consolidation between Fibonacci pivot and resistance zones.

Glenmark Pharmaceuticals Ltd Moving Average Analysis

Moving averages are key indicators in Glenmark Pharmaceuticals Ltd technical analysis for identifying trend direction.

• 10 EMA: 2116.49
• 20 EMA: 2079.99
• 30 EMA: 2058.53
• 50 EMA: 2032.33
• 100 EMA: 1989.95
• 200 EMA: 1899.56

Trend Logic

Glenmark Pharmaceuticals Ltd technical analysis indicates bearish pressure, with price trading below key moving averages.

Long-term trend in Glenmark Pharmaceuticals Ltd technical analysis remains positive above 200 EMA.

Glenmark Pharmaceuticals Ltd Technical Indicators Overview

Momentum Indicators

• RSI: 68.71
• MACD: 41.34
• Signal: 29.61
• ADX: 12.81
• Momentum: 186.60

RSI Logic

Glenmark Pharmaceuticals Ltd technical analysis shows RSI in neutral range, suggesting consolidation.

MACD Logic

Glenmark Pharmaceuticals Ltd technical analysis indicates bearish momentum with MACD below signal line.

Glenmark Pharmaceuticals Ltd Overall Recommendation

• Overall Recommendation Score: 0.60
• Moving Average Recommendation: 0.93
• Other Indicators Recommendation: 0.27

Overall Glenmark Pharmaceuticals Ltd technical analysis sentiment remains neutral with mixed signals.

Glenmark Pharmaceuticals Ltd Technical Analysis Conclusion

Glenmark Pharmaceuticals Ltd technical analysis suggests that traders should closely monitor price action around ₹2136.70 and key pivot level 2046.17. Breakouts above resistance or breakdown below support will define the next trend in Glenmark Pharmaceuticals Ltd technical analysis.

Investors searching for Glenmark Pharmaceuticals Ltd Technical Analysis should track moving averages, RSI levels, and volume trends to identify potential entry and exit opportunities. As market conditions change, Glenmark Pharmaceuticals Ltd technical analysis will continue to play a crucial role in short-term trading and long-term investment strategies.